Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2014-03-06 13:45:27 |
Versijas komentārs | |
Teksts |
Olainfarm will
Hold Fourth Quarter 2013 Investor Conference
Webinar
AS „Olainfarm”
invites shareholders, investors, mass media representatives and
other stakeholders to join its fourth quarter 2013 investor
conference webinar scheduled on March 11, 2014 at 16:00
(EET). Webinar will be
hosted by the member of the management board Salvis Lapiņš. The
presentation will be in English. During the webinar
Salvis Lapiņš will inform about AS “Olainfarm” latest activities
and analyse the unaudited financial results of the year 2013.
After the
presentation investors will be welcomed to ask
questions. Due to the limited webinar time, please send
in your questions in advance till March 10 to e-mail: ieva.kadakovska@nasdaqomx.com.
What is
webinar? How to join the
webinar? Additional
information on the webinar A/s OlainFarm is one of the
biggest pharmaceutical companies in Latvia with 40 years of
experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 30 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia.
Information
prepared by: |
Pielikumi |
|